Literature DB >> 13374336

Treatment of chronic myeloid leukaemia with mercaptopurine.

J R FOUNTAIN.   

Abstract

Entities:  

Keywords:  LEUKEMIA, MYELOCYTIC/therapy; MERCAPTOPURINE/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13374336      PMCID： PMC2036146          DOI： 10.1136/bmj.2.5005.1345

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Clinical observations of the treatment of leukemia and allied disorders with 6-mercaptopurine.

Authors:  J R FOUNTAIN
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

2.  Myleran in treatment of chronic myeloid leukaemia.

Authors:  E K BLACKBURN; G M KING; H T SWAN
Journal:  Br Med J       Date:  1956-04-14

3.  Myleran in chronic myeloid leukaemia.

Authors:  D A GALTON; M TILL
Journal:  Lancet       Date:  1955-02-26       Impact factor: 79.321

4.  Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.

Authors:  J H BURCHENAL; M L MURPHY; R R ELLISON; M P SYKES; T C TAN; L A LEONE; D A KARNOFSKY; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

5.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321
  5 in total
  1 in total

1.  Chemotherapy in malignant disease. Introduction.

Authors:  D A GALTON
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.